Clinical Trials on Acute Respiratory Syndrome Coronavirus 2 (For Phase 2 Exploratory Group)

Total 502 results

Apsen Farmaceutica S.A.
Federal University of São Paulo

Withdrawn

Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19)

Coronavirus Infections | SARS-CoV 2 | Pulmonary Disease | SARS (Severe Acute Respiratory Syndrome)

Brazil
University of Minnesota
National Institute of Allergy and Infectious Diseases (NIAID); National Institutes...

Recruiting

Respiratory Virus Hospitalization Study (FLU 003 Plus)

Influenza | Novel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV) | Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)

United States, Australia, Spain, Denmark, Greece, Argentina, United Kingdom, Belgium, Chile, Germany, Peru, Thailand
Grupo Cooperativo de Hemopatías Malignas

Completed

Treatment of SARS Caused by COVID-19 With Ruxolitinib

COVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2

Mexico
NMC Specialty Hospital

Completed

Communication in ICU During COVID-19

Severe Acute Respiratory Syndrome | COVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2

United Arab Emirates
University of Calgary

Unknown

Tocilizumab in Coronavirus-19 Positive Patients

COVID-19 | Inflammation | Covid19 | Coronavirus | Severe Acute Respiratory Syndrome Coronavirus 2
American Dental Association

Completed

COVID-19 Related Health and Infection Control Practices Among Dentists

Severe Acute Respiratory Syndrome Coronavirus 2

United States
Università degli Studi dell'Insubria

Unknown

Monocytes and NK Cells Activity in Covid-19 Patients

COVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2 | Immunomodulation

Italy
Nemechek Technologies

Completed

Vagus Nerve Stimulation ARDS Prevention Trial for COVID-19 Hospitalized Patients

Severe Acute Respiratory Syndrome Coronavirus 2

Argentina
Apellis Pharmaceuticals, Inc.

Completed

A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19

Severe Acute Respiratory Syndrome | Coronavirus Infection | Covid-19 | COVID | Acute Respiratory Distress Syndrome | Coronavirus | Ards | Severe Acute Respiratory Syndrome Coronavirus 2 | Sars-CoV2

United States, Brazil
Assistance Publique - Hôpitaux de Paris

Completed

Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS (STROMA-CoV2)

Severe Acute Respiratory Syndrome Coronavirus 2 | Severe Acute Respiratory Distress Syndrome

France
Goethe University

Completed

Evaluation of Sedation in COVID-19 ARDS

Severe Acute Respiratory Syndrome Coronavirus 2 | Prone Position | Pulmonary Ventilation | Hypnotics and Sedatives

Germany
Sheng-Teng Huang

Completed

Evaluation of KGR Prescriptions in Suppressing COVID-19 Infection.

Coronavirus Disease 2019 | Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Taiwan
University of Saskatchewan
Government of Canada; Government of Saskatchewan

Active, not recruiting

A Clinical Trial to Study the COVAC-1 Booster Dose in Generally Healthy Adults

Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Canada
NeuroActiva, Inc.
Biomed Industries, Inc.

Recruiting

NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection (NATADEX)

Coronavirus Infection | Severe Acute Respiratory Syndrome Coronavirus 2 | Severe Acute Respiratory Infection

United States
60P Australia Pty Ltd

Not yet recruiting

A Clinical Evaluation of the Safety and Efficacy of Randomized Placebo Versus the 8-aminoquinoline Tafenoquine for Early Symptom Resolution in Patients With Mild to Moderate COVID 19 Disease and Low Risk of Disease Progression

Infectious Disease | SARS-CoV-2 | Severe Acute Respiratory Syndrome Coronavirus 2 | COVID 19 Disease | Mild to Moderate COVID 19 Disease
Jeffrey Jenks, MD, MPH
Astellas Pharma Global Development, Inc.

Terminated

Isavuconazole for the Prevention of COVID-19-associated Pulmonary Aspergillosis (Isavu-CAPA)

Severe Acute Respiratory Syndrome Coronavirus 2 | Aspergillosis Invasive

United States
ANRS, Emerging Infectious Diseases
University of Bordeaux; PACCI Program

Unknown

Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial (INTENSE-COV)

COVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2 | COVID-19 Drug Treatment

Côte D'Ivoire
University of Pennsylvania

Withdrawn

COVIDNOCHE Trial (HFNO Versus CPAP Helmet) in COVID-19 Pneumonia (COVIDNOCHE)

Pneumonia, Viral | COVID | Severe Acute Respiratory Syndrome Coronavirus 2 | Hypoxemic Respiratory Failure

United States
University of Calgary
Alberta Health services

Unknown

CORONA (COvid pRONe hypoxemiA): Prone Positioning for Hypoxemic COVID-19 Patients With Do-not-intubate Goals (CORONA)

COVID-19 | Acute Respiratory Distress Syndrome | ARDS | Severe Acute Respiratory Syndrome Coronavirus 2 | Hypoxemic Respiratory Failure

Canada
Centre Hospitalier Universitaire Dijon

Not yet recruiting

Evaluation of the Prognostic Value of T7 and T12 Slices on Mortality in Resuscitation Patients With ARDS Caused by SARS-COV2 Infection (MUSCOV)

Acute Respiratory Distress Syndrom (SARS-Cov 2)
Fundacion Clinica Valle del Lili

Unknown

Surgery and Lung Ultrasound in COVID-19 Infection (SOUNDS)

Lung Diseases | Covid19 | Ultrasonography | Severe Acute Respiratory Syndrome Coronavirus 2 | Surgical Procedure

Colombia
University of North Carolina, Chapel Hill

Completed

ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19

Coronavirus Infections | Coronaviridae Infections | RNA Virus Infections | Virus Diseases | Asymptomatic Condition | Severe Acute Respiratory Syndrome Coronavirus 2 | Communicable Disease | Infection Viral

United States
University of Washington
National Institute of Allergy and Infectious Diseases (NIAID); Fred Hutchinson...

Completed

Index Individuals in SARS-CoV-2 Prevention Research Studies (COVID-19 Index Individuals Companion Study) (IICov19PRS)

COVID-19 | Coronavirus Infection | SARS-CoV-2 Infection | SARS (Severe Acute Respiratory Syndrome)

United States
Hopital of Melun

Completed

Plasma SARS-CoV-2 RNA Levels in Critically Ill COVID-19 Patients (pRNA-COVID-ICU)

COVID-19 Pneumonia | ARDS Due to Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2

France
A.O. Ospedale Papa Giovanni XXIII

Completed

An Observational Study of the Use of Siltuximab (SYLVANT) in Patients Diagnosed With COVID-19 Infection Who Have Developed Serious Respiratory Complications (SISCO)

Severe Acute Respiratory Syndrome (ARDS) Secondary to SARS-COV-2 Infection

Italy
US Biotest, Inc.

Terminated

Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19

SARS-CoV-2 Infection | Respiratory Distress Syndrome, Adult | Adult Respiratory Distress Syndrome | COVID-19 Virus Infection | SARS Coronavirus 2 Infection | 2019 Novel Coronavirus Infection

United States
The Board of Medicine
Apollo Neuroscience, Inc.

Recruiting

Effect of Apollo Wearable on Long COVID-19 Symptoms.

Post-acute Sequelae of SARS-COV-2 Infection

United States
Stanford University
Pfizer

Completed

Paxlovid for Treatment of Long Covid (STOP-PASC)

Long COVID | Post-acute Sequelae of SARS-CoV-2 Infection

United States
Azienda Ospedaliera Universitaria Integrata Verona
Charite University, Berlin, Germany; Institut National de la Santé Et de la... and other collaborators

Recruiting

Follow-up of Covid-19 Long Term Sequelae

Coronavirus Infections | Covid19 | Coronavirus Disease 2019 | Corona Virus Infection | Coronavirus | SARS-CoV2 Infection | COVID-19 Pneumonia | SARS-CoV-2 Acute Respiratory Disease | SARS (Severe Acute Respiratory Syndrome) | COVID-19 Respiratory Infection | SARS (Disease) | COVID-19 Acute Respiratory Distress... and other conditions

Italy, Belgium, Congo, France, Netherlands, Spain
Family Health Centers of San Diego

Active, not recruiting

Does a Technology Enabled Multi-disciplinary Team-based Care Model for the Management of Long COVID and Other Fatiguing Illnesses Improve Clinical Care of Patients and Represent a Sustainable Approach Within a Federally Qualified Health Center? (LC&FIRP)

Chronic Fatigue Syndrome | SARS-CoV-2 Acute Respiratory Disease | Post COVID-19 Condition | Myalgic Encephalomyelitis | Post-acute Sequelae of SARS-COV-2 Infection

United States
Azienda USL Toscana Nord Ovest
Azienda Ospedaliero, Universitaria Pisana; Azienda Ospedaliera Universitaria... and other collaborators

Unknown

Ruxolitinib for the Treatment of Acute Respiratory Distress Syndrome in Patients With COVID-19 Infection (RESPIRE)

Severe Acute Respiratory Syndrome Coronavirus 2
Hospital Universitario Ramon y Cajal

Recruiting

Pulmonary Inflammation in COVID-19 ARDS (IMPU-COVID)

COVID-19 Acute Respiratory Distress Syndrome | ARDS Due to Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2

Spain
Hôpital Européen Marseille

Active, not recruiting

Pulmonary Fibrosis During Severe COVID-19 Pneumonia (FIBRO-COVID)

Pulmonary Fibrosis | Acute Respiratory Distress Syndrome | Severe Acute Respiratory Syndrome Coronavirus 2

France
Hospital Universitari Joan XXIII de Tarragona.
Sociedad Española de Medicina Intensiva,critica y unidades coronarias

Recruiting

Characteristics of Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection (COVID-19) (GETCOV-2)

SARS-CoV2 Infection

Spain
Rabin Medical Center

Terminated

Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19

Glucose Metabolism Disorders | Respiratory Tract Diseases | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Endocrine System Diseases | COVID 19 | Coronavirus | Metabolic Disease | Severe Acute Respiratory Syndrome Coronavirus 2 | Sars-CoV2 | Hormones | Hypoglycemic Agents | Incretins | Dipeptidyl-Peptidase IV Inhibitors and other conditions

Israel
Medical University Innsbruck

Recruiting

Neurological Outcome After SARS-CoV-2 Infection (ATTRACT)

SARS-CoV-2 | Post-acute COVID-19 Syndrome

Austria
NYU Langone Health

Recruiting

Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 (PASC) Using TSPO Positron Emission Tomography (PET) and MRI

Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 Infection

United States
University of Washington
Bill and Melinda Gates Foundation

Completed

Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP)

COVID-19 | Corona Virus Infection | SARS-CoV-2 | SARS (Severe Acute Respiratory Syndrome)

United States
St. Olavs Hospital
The Research Council of Norway; Helse Nord-Trøndelag HF; Alesund Hospital; Namsos... and other collaborators

Completed

The Corona Study of Middle Norway (CUT COVID-19)

SARS-CoV-2 Acute Respiratory Disease | SARS-CoV-2 Sepsis | SARS CoV 2 Infection

Norway
University of Minnesota
National Institute of Allergy and Infectious Diseases (NIAID); National Institutes... and other collaborators

Completed

Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)

COVID-19 | COVID | SARS-CoV-2 | SARS (Severe Acute Respiratory Syndrome)

Spain, United States, Denmark, United Kingdom, Greece, Japan, Nigeria
Hospital Departamental de Villavicencio
Cooperative University of Colombia; Clinica Primavera; Clínica Meta; Grupo de Investigación...

Withdrawn

Characteristics of Patients With COVID-19 in Meta State, Colombia

SARS-CoV 2 | COVID | SARS (Severe Acute Respiratory Syndrome) | SARS (Disease) | SARS Pneumonia
CureVac
Coalition for Epidemic Preparedness Innovations

Completed

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19

Severe Acute Respiratory Syndrome | COVID-19 | SARS-CoV-2 | Coronavirus

Belgium, Germany
Rennes University Hospital

Completed

Human Ab Response & immunoMONItoring of COVID-19 Patients (HARMONICOV)

Acute Respiratory Distress Syndrome | SARS-CoV-2 Coronavirus

France
CureVac
German Federal Ministry of Education and Research

Completed

A Study to Evaluate the Safety and Immunogenicity of Vaccine CVnCoV in Healthy Adults in Germany for COVID-19

Severe Acute Respiratory Syndrome | Covid19 | SARS-CoV-2 | Coronavirus

Germany
CureVac
German Federal Ministry of Education and Research

Completed

A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19

Severe Acute Respiratory Syndrome | Covid19 | SARS-CoV-2 | Coronavirus

Panama, Peru
University of Lausanne Hospitals

Completed

Physiological Response to Prone Position in COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS)

ARDS | Sars-CoV-2 Infection

Switzerland
Ain Shams University
Misr International University

Completed

Effect of N-acetylcysteine on Oxidative Stress in COVID-19 Patients

Corona Virus Infection | Corona Virus Disease 19 (Covid19) | Severe Acute Respiratory Syndrome Coronavirus 2(SARS-CoV2)

Egypt
Centre Scientifique de Monaco
Department of Health Affairs, Monaco

Recruiting

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Buccal Screening Evaluation Using an RT-PCR Assay and a Rapid ELISA Test Among Symptomatic and Asymptomatic Patients (CORDAGES)

COVID-19 | SARS-CoV-2

Monaco
Maimónides Biomedical Research Institute of Córdoba
Dynamic Solutions; Faes Farma, S.A.; Junta de Andalucía - Consejería de Salud...

Completed

Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome (COVIDIOL)

SARS-CoV 2 | COVID19 | Cytokine Storm | Cytokine Release Syndrome | SARS (Severe Acute Respiratory Syndrome)

Spain
CureVac

Terminated

COVID-19: A Study to Evaluate Safety, Reactogenicity and Immunogenicity of the SARS-CoV-2 mRNA Vaccine CVnCoV in Adults With Co-morbidities

Severe Acute Respiratory Syndrome | Covid19 | SARS-CoV-2 | Coronavirus

Belgium

Clinical Trials on Acute Respiratory Syndrome Coronavirus 2 (For Phase 2 Exploratory Group)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Africa

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations